UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$591M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$493M |
| 3 |
Broadcom
AVGO
|
+$481M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$460M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$503M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$370M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$368M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$279M |
| 5 |
Fidelity National Information Services
FIS
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.13% |
| 2 | Financials | 7.1% |
| 3 | Healthcare | 6% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Industrials | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5601
AMES National
ATLO
$277M
| $261K | ﹤0.01% |
12,215
+7,111
| +139% | +$130K |
|
5602
PUT
Lantheus
LNTH
$6.59B
| $260K | ﹤0.01% |
+4,200
| New | +$285K |
|
5603
Lexicon Pharmaceuticals
LXRX
$1.1B
| $260K | ﹤0.01% |
169,616
+44,254
| +35% | +$52.6K |
|
5604
PUT
Aspen Aerogels
ASPN
$518M
| $259K | ﹤0.01% |
+16,400
| New | +$169K |
|
5605
Vitamin Cottage Natural Grocers
NGVC
$654M
| $258K | ﹤0.01% |
16,135
+7,487
| +87% | +$109K |
|
5606
Rayonier Advanced Materials
RYAM
$610M
| $257K | ﹤0.01% |
63,543
+21,265
| +50% | +$69.9K |
|
5607
PRA Group
PRAA
$755M
| $257K | ﹤0.01% |
9,807
-953,714
| -99% | -$17.8M |
|
5608
MDB Capital Holdings
MDBH
$30.5M
| $257K | ﹤0.01% |
22,258
+7,170
| +48% | +$74.8K |
|
|
SILK
5609
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $257K | ﹤0.01% |
20,906
+14,648
| +234% | +$137K |
|
5610
Timberland Bancorp
TSBK
$351M
| $256K | ﹤0.01% |
8,150
+3,989
| +96% | +$117K |
|
5611
MeiraGTx Holdings
MGTX
$1.21B
| $256K | ﹤0.01% |
36,477
+20,765
| +132% | +$103K |
|
5612
Core Molding Technologies
CMT
$234M
| $256K | ﹤0.01% |
13,816
+1,775
| +15% | +$38.8K |
|
5613
Sutro Biopharma
STRO
$421M
| $256K | ﹤0.01% |
5,959
+2,362
| +66% | +$75K |
|
5614
908 Devices
MASS
$364M
| $255K | ﹤0.01% |
22,744
+10,290
| +83% | +$70.3K |
|
5615
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
$2.08B
| $254K | ﹤0.01% |
2,509
+2,480
| +8,552% | +$247K |
|
5616
John Wiley & Sons Class B
WLYB
$2.73B
| $254K | ﹤0.01% |
7,900
-24
| -0.3% | -$746 |
|
5617
PUT
LivaNova
LIVN
$4.2B
| $254K | ﹤0.01% |
4,900
| – | – |
|
5618
Commercial Vehicle Group
CVGI
$147M
| $253K | ﹤0.01% |
36,028
+18,105
| +101% | +$123K |
|
5619
Capital Bancorp
CBNK
$615M
| $253K | ﹤0.01% |
10,435
+5,156
| +98% | +$109K |
|
5620
NovoCure
NVCR
$1.91B
| $252K | ﹤0.01% |
16,904
+12,193
| +259% | +$163K |
|
|
QVMT
5621
Invesco S&P 500 Concentrated QVM ETF
QVMT
$134M
| $252K | ﹤0.01% |
5,701
+211
| +4% | +$8.64K |
|
5622
US Treasury 10 Year Note ETF
UTEN
$288M
| $251K | ﹤0.01% |
+5,577
| New | +$241K |
|
5623
Norwood Financial Corp
NWFL
$368M
| $251K | ﹤0.01% |
7,629
+3,478
| +84% | +$97.9K |
|
5624
Nuveen Municipal Income
NMI
$130M
| $251K | ﹤0.01% |
27,285
+8,750
| +47% | +$76.7K |
|
|
YMAB
5625
DELISTED
Y-mAbs Therapeutics
YMAB
| $251K | ﹤0.01% |
36,744
+17,211
| +88% | +$99.5K |
|
Similar funds
UBS Group's Q4 2023 Portfolio in Review
As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.
- UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
- UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
- UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
- UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
- UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
- UBS Group opened 1,223 new positions and closed 1,397 in Q4 2023.
- UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.